加拿大与不平等有关的传染病经济负担。

Canada Diener, Dugas
{"title":"加拿大与不平等有关的传染病经济负担。","authors":"Canada Diener, Dugas","doi":"10.14745/CCDR.V42IS1A02","DOIUrl":null,"url":null,"abstract":"Background\nCommunicable diseases cause a significant burden on society in terms of health care expenditures and their health impact on individuals. Cost-of-illness studies estimate the total economic burden of illness and injury.\n\n\nObjective\nTo identify the economic burden of illness for communicable diseases in Canada, and to derive the costs associated with inequalities based on income and hospital expenditures.\n\n\nMethods\nData were derived from the Economic Burden of Illness in Canada (EBIC) database, for the year 2008. Data for communicable diseases were extracted and compared to the overall results. Data on income level was available for hospital expenditures, and was analyzed by income quintile.\n\n\nResults\nThe total costs attributable to communicable diseases in Canada were $8.3 billion, which represented 9% of the total costs that could be attributed to a specific disease or diagnostic category. Indirect costs accounted for 44% of total communicable disease costs and represented a more significant proportion of the economic burden related to communicable diseases compared to non-communicable diseases. When hospital costs by income quintile were analyzed, a clear inverse relationship was found between income and hospital expenditures. The costs associated with this inequality in 2008 were $308 million. The current estimates are likely to be an underestimate due to the conservative assumptions made in the analysis.\n\n\nConclusion\nThe cost of communicable disease in Canada is sizable and there is a clear correlation between lower income and higher hospital costs. Further research is needed to better account for co-morbid conditions and to better estimate the value of lost productivity related to disability arising from communicable diseases.","PeriodicalId":94304,"journal":{"name":"Canada communicable disease report = Releve des maladies transmissibles au Canada","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Inequality-related economic burden of communicable diseases in Canada.\",\"authors\":\"Canada Diener, Dugas\",\"doi\":\"10.14745/CCDR.V42IS1A02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background\\nCommunicable diseases cause a significant burden on society in terms of health care expenditures and their health impact on individuals. Cost-of-illness studies estimate the total economic burden of illness and injury.\\n\\n\\nObjective\\nTo identify the economic burden of illness for communicable diseases in Canada, and to derive the costs associated with inequalities based on income and hospital expenditures.\\n\\n\\nMethods\\nData were derived from the Economic Burden of Illness in Canada (EBIC) database, for the year 2008. Data for communicable diseases were extracted and compared to the overall results. Data on income level was available for hospital expenditures, and was analyzed by income quintile.\\n\\n\\nResults\\nThe total costs attributable to communicable diseases in Canada were $8.3 billion, which represented 9% of the total costs that could be attributed to a specific disease or diagnostic category. Indirect costs accounted for 44% of total communicable disease costs and represented a more significant proportion of the economic burden related to communicable diseases compared to non-communicable diseases. When hospital costs by income quintile were analyzed, a clear inverse relationship was found between income and hospital expenditures. The costs associated with this inequality in 2008 were $308 million. The current estimates are likely to be an underestimate due to the conservative assumptions made in the analysis.\\n\\n\\nConclusion\\nThe cost of communicable disease in Canada is sizable and there is a clear correlation between lower income and higher hospital costs. Further research is needed to better account for co-morbid conditions and to better estimate the value of lost productivity related to disability arising from communicable diseases.\",\"PeriodicalId\":94304,\"journal\":{\"name\":\"Canada communicable disease report = Releve des maladies transmissibles au Canada\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-02-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canada communicable disease report = Releve des maladies transmissibles au Canada\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14745/CCDR.V42IS1A02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canada communicable disease report = Releve des maladies transmissibles au Canada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14745/CCDR.V42IS1A02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

背景:就卫生保健支出及其对个人健康的影响而言,传染病给社会造成了重大负担。疾病成本研究估计了疾病和伤害的总经济负担。目的确定加拿大传染性疾病的经济负担,并根据收入和医院支出得出与不平等相关的成本。方法数据来源于2008年加拿大疾病经济负担(EBIC)数据库。提取传染病数据并与总体结果进行比较。有关医院支出的收入水平数据可用,并按收入五分位数进行分析。结果加拿大可归因于传染病的总费用为83亿美元,占可归因于特定疾病或诊断类别的总费用的9%。间接费用占传染病总费用的44%,与非传染性疾病相比,在与传染病有关的经济负担中所占比例更大。当按收入五分位数分析医院费用时,发现收入与医院支出之间存在明显的负相关关系。2008年,与这种不平等相关的成本为3.08亿美元。由于分析中所作的保守假设,目前的估计可能被低估了。结论加拿大传染性疾病的费用相当可观,低收入与高住院费用之间存在明显的相关性。需要进一步的研究,以更好地解释合并症,并更好地估计与传染病引起的残疾有关的生产力损失的价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Inequality-related economic burden of communicable diseases in Canada.
Background Communicable diseases cause a significant burden on society in terms of health care expenditures and their health impact on individuals. Cost-of-illness studies estimate the total economic burden of illness and injury. Objective To identify the economic burden of illness for communicable diseases in Canada, and to derive the costs associated with inequalities based on income and hospital expenditures. Methods Data were derived from the Economic Burden of Illness in Canada (EBIC) database, for the year 2008. Data for communicable diseases were extracted and compared to the overall results. Data on income level was available for hospital expenditures, and was analyzed by income quintile. Results The total costs attributable to communicable diseases in Canada were $8.3 billion, which represented 9% of the total costs that could be attributed to a specific disease or diagnostic category. Indirect costs accounted for 44% of total communicable disease costs and represented a more significant proportion of the economic burden related to communicable diseases compared to non-communicable diseases. When hospital costs by income quintile were analyzed, a clear inverse relationship was found between income and hospital expenditures. The costs associated with this inequality in 2008 were $308 million. The current estimates are likely to be an underestimate due to the conservative assumptions made in the analysis. Conclusion The cost of communicable disease in Canada is sizable and there is a clear correlation between lower income and higher hospital costs. Further research is needed to better account for co-morbid conditions and to better estimate the value of lost productivity related to disability arising from communicable diseases.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Characteristics associated with SARS-CoV-2 testing, infection and vaccine uptake among essential non-healthcare workers in Montréal, 2021. Device and surgical procedure-related infections in Canadian acute care hospitals, 2018-2022. Efficacy, effectiveness and immunogenicity of reduced HPV vaccination schedules: A review of available evidence. Thematic description of factors linked with extended-spectrum beta-lactamase-producing Enterobacteriaceae in humans. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2018-2022.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1